All content for MSACL is the property of MSACL and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
What's happening in the clinical lab community including publications in JMSACL and interviews with the Early Career Network.
The Regulatory Landscape of Laboratory Developed Tests (LDT): A Laboratorian Perspective
MSACL
56 minutes 30 seconds
1 year ago
The Regulatory Landscape of Laboratory Developed Tests (LDT): A Laboratorian Perspective
The FDA released a proposed LDT rule and stated it will “end its enforcement discretion” of LDTs. Previously, the FDA explored other avenues for regulating LDTs. We will discuss questions relevant to the draft rule and implications to laboratory medicine, including, but not limited to:
- What are possible implications of FDA regulation of LDTs?
- Is the FDA the appropriate mechanism for this LDT oversight?
- What about modernization of CLIA?
- What would be the financial cost?
- What would be the diagnostic cost?
MSACL
What's happening in the clinical lab community including publications in JMSACL and interviews with the Early Career Network.
